Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19 - Concepedia

Concepedia

Publication | Open Access

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19

DOI Full Paper Access

104

Citations

34

References

2020

Year

Masaya Sugiyama, Noriko Kinoshita, Satoshi Ide, Hidetoshi Nomoto, Takato Nakamoto, Sho Saito, Masahiro Ishikane, Satoshi Kutsuna, Kayoko Hayakawa, Masao Hashimoto,

Disease ProgressionSevere/critical DiseaseMedicineSerum Ccl17 LevelImmunologyCovid-19 PandemicInflammatory MarkerPredictive MarkerCovid-19 EpidemiologyPublic HealthChronic Viral InfectionLaboratory MedicineEpidemiologyCovid-19

References

	Year	Citations

Page 1

Page 1